THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 93 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $623,000 | +66.6% | 59,032 | +15.2% | 0.00% | +100.0% |
| Q3 2021 | $374,000 | -50.8% | 51,250 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $760,000 | -44.2% | 51,250 | -22.6% | 0.00% | -60.0% |
| Q1 2021 | $1,362,000 | +16.0% | 66,250 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $1,174,000 | +128.0% | 66,250 | +91.8% | 0.00% | +100.0% |
| Q3 2020 | $515,000 | +181.4% | 34,550 | +287.6% | 0.00% | +100.0% |
| Q2 2020 | $183,000 | -9.9% | 8,914 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $203,000 | +8.6% | 8,914 | -7.1% | 0.00% | +100.0% |
| Q3 2019 | $187,000 | -38.9% | 9,600 | -50.0% | 0.00% | -50.0% |
| Q2 2019 | $306,000 | -9.2% | 19,200 | +64.1% | 0.00% | 0.0% |
| Q1 2019 | $337,000 | +51.1% | 11,700 | +21.9% | 0.00% | +100.0% |
| Q4 2018 | $223,000 | -33.8% | 9,600 | -17.9% | 0.00% | -50.0% |
| Q3 2018 | $337,000 | +22.5% | 11,700 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $275,000 | -51.2% | 12,000 | -50.0% | 0.00% | -50.0% |
| Q1 2018 | $563,000 | -15.0% | 24,000 | -2.0% | 0.00% | -20.0% |
| Q4 2017 | $662,000 | 0.0% | 24,500 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $662,000 | -32.0% | 24,500 | 0.0% | 0.01% | -37.5% |
| Q2 2017 | $974,000 | +9.4% | 24,500 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $890,000 | +6.2% | 24,500 | -7.5% | 0.01% | -11.1% |
| Q4 2016 | $838,000 | -2.8% | 26,500 | +8.2% | 0.01% | -10.0% |
| Q3 2016 | $862,000 | +53.7% | 24,500 | 0.0% | 0.01% | +66.7% |
| Q2 2016 | $561,000 | +87.0% | 24,500 | +50.3% | 0.01% | +50.0% |
| Q1 2016 | $300,000 | -5.4% | 16,300 | -15.1% | 0.00% | 0.0% |
| Q4 2015 | $317,000 | +69.5% | 19,200 | +12.9% | 0.00% | +100.0% |
| Q3 2015 | $187,000 | -8.3% | 17,000 | +8.3% | 0.00% | 0.0% |
| Q2 2015 | $204,000 | -22.1% | 15,700 | +4.0% | 0.00% | -33.3% |
| Q1 2015 | $262,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |